Search

Your search keyword '"FERRARI, CARLO"' showing total 1,397 results

Search Constraints

Start Over You searched for: Author "FERRARI, CARLO" Remove constraint Author: "FERRARI, CARLO"
1,397 results on '"FERRARI, CARLO"'

Search Results

201. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

203. Cooperative behaviors in multi-robot systems through implicit communication

204. International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C

207. Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C

208. Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment.

209. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences

219. PaSo-Team 2000

220. Interferon (IFN) - (gamma) - inducible protein - 10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-(alpha)2a and ribavirin for chronic hepatitis C virus infection

222. PaSo-Team’99

224. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea

225. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

235. Impact of COVID-19 Pandemic on Cirrhotics with Hepatocellular Carcinoma During Follow-Up: Direct Consequences or Collateral Damages?

236. Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study

240. Assessment of patient clinical descriptions and pathogenic variants from gene panel sequences in the CAGI‐5 intellectual disability challenge

241. Update of the statements on biology and clinical impact of occult hepatitis B virus infection

242. A global scientific strategy to cure hepatitis B

244. PS-080-Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold

245. Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE‐I Part II)

246. Immunopathogenesis of hepatitis C virus infection

248. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

Catalog

Books, media, physical & digital resources